191 related articles for article (PubMed ID: 16084483)
1. [Treatment of malignant intestinal obstruction. A prospective study over 80 cases].
Arvieux C; Laval G; Mestrallet JP; Stefani L; Villard ML; Cardin N
Ann Chir; 2005 Sep; 130(8):470-6. PubMed ID: 16084483
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center.
Laval G; Arvieux C; Stefani L; Villard ML; Mestrallet JP; Cardin N
J Pain Symptom Manage; 2006 Jun; 31(6):502-12. PubMed ID: 16793490
[TBL] [Abstract][Full Text] [Related]
3. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
Weber C; Zulian GB
Am J Hosp Palliat Care; 2009; 26(2):84-8. PubMed ID: 19088264
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin.
van Ooijen B; van der Burg ME; Planting AS; Siersema PD; Wiggers T
Surg Gynecol Obstet; 1993 May; 176(5):469-74. PubMed ID: 8480270
[TBL] [Abstract][Full Text] [Related]
5. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial.
Tuca A; Roca R; Sala C; Porta J; Serrano G; González-Barboteo J; Gómez-Batiste X
J Pain Symptom Manage; 2009 Feb; 37(2):259-70. PubMed ID: 18789638
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous endoscopic gastrostomy tube occlusion in malignant peritoneal carcinomatosis-induced bowel obstruction.
Vashi PG; Dahlk S; Vashi RP; Gupta D
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1069-73. PubMed ID: 21975697
[TBL] [Abstract][Full Text] [Related]
8. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy.
Campagnutta E; Cannizzaro R; Gallo A; Zarrelli A; Valentini M; De Cicco M; Scarabelli C
Gynecol Oncol; 1996 Jul; 62(1):103-5. PubMed ID: 8690280
[TBL] [Abstract][Full Text] [Related]
9. [Study of symptoms in terminally ill patients with ovarian carcinoma].
Sun XG; Wu M; Ma SQ; Li CY; Jin LN; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):192-5. PubMed ID: 17537307
[TBL] [Abstract][Full Text] [Related]
10. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
Hisanaga T; Shinjo T; Morita T; Nakajima N; Ikenaga M; Tanimizu M; Kizawa Y; Maeno T; Shima Y; Hyodo I
Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
[TBL] [Abstract][Full Text] [Related]
11. Medical management of intestinal obstruction in terminal care.
Frank C
Can Fam Physician; 1997 Feb; 43():259-65. PubMed ID: 9040913
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
Shima Y; Ohtsu A; Shirao K; Sasaki Y
Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369
[TBL] [Abstract][Full Text] [Related]
13. Adrenal insufficiency in intestinal obstruction from carcinomatosis peritonei--a factor of potential importance in symptom palliation.
Poon D; Cheung YB; Tay MH; Lim WT; Lim ST; Wong NS; Koo WH
J Pain Symptom Manage; 2005 Apr; 29(4):411-8. PubMed ID: 15857745
[TBL] [Abstract][Full Text] [Related]
14. Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement.
Picus D; Marx MV; Weyman PJ
AJR Am J Roentgenol; 1988 Feb; 150(2):295-7. PubMed ID: 2447767
[TBL] [Abstract][Full Text] [Related]
15. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
Caceres A; Zhou Q; Iasonos A; Gerdes H; Chi DS; Barakat RR
Gynecol Oncol; 2008 Mar; 108(3):482-5. PubMed ID: 18190953
[TBL] [Abstract][Full Text] [Related]
16. [Intestinal obstruction in cancer patients. Palliative treatment].
Costa I; Conçalves F
Acta Med Port; 1997 May; 10(5):381-5. PubMed ID: 9312984
[TBL] [Abstract][Full Text] [Related]
17. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for bowel obstruction with peritoneal carcinomatosis.
Laval G; Marcelin-Benazech B; Guirimand F; Chauvenet L; Copel L; Durand A; Francois E; Gabolde M; Mariani P; Rebischung C; Servois V; Terrebonne E; Arvieux C; ; ; ; ;
J Pain Symptom Manage; 2014 Jul; 48(1):75-91. PubMed ID: 24798105
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of duodenal stenting: a prospective multicenter study.
Graber I; Dumas R; Filoche B; Boyer J; Coumaros D; Lamouliatte H; Legoux JL; Napoléon B; Ponchon T;
Endoscopy; 2007 Sep; 39(9):784-7. PubMed ID: 17703386
[TBL] [Abstract][Full Text] [Related]
20. SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction.
Laval G; Rousselot H; Toussaint-Martel S; Mayer F; Terrebonne E; François E; Brixi H; Nguyen T; Bourdeix I; Bisot-Locard S; Zelek L;
Bull Cancer; 2012 Feb; 99(2):E1-9. PubMed ID: 22265994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
